Filing Details
- Accession Number:
- 0001493152-20-016097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-17 16:30:30
- Reporting Period:
- 2020-08-13
- Accepted Time:
- 2020-08-17 16:30:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1164762 | Md Louis Gleckel | 621 N. Shady Retreat Road Doylestown, PA 18901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0005 | Acquisiton | 2020-08-13 | 50,000 | $2.75 | 273,840 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These shares were purchased in a private transaction from Ted Karkus, Chairman and Chief Executive Officer of the Issuer, pursuant to the terms of a Stock Purchase Agreement
Billionaire Hedge Funds
